• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Australia·Basic Materials·EL8.AX
Share

Elevate Uranium Ltd Stocks

A$ 0.23Last Updated 17.07.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

A$ 63.14M

A$ 0.23
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Headquartered in West Perth, Australia, Elevate Uranium Ltd focuses on the exploration and evaluation of uranium reserves, a business it has pursued since its incorporation in 1978. The company's key operations are distributed across two main regions: Namibia, where it manages projects like Koppies, Hirabeb, Marenica, and Namib IV; and Australia. In Australia, Elevate Uranium fully owns the Angela, Thatcher Soak, Oobagooma, and Minerva project areas, and participates in joint ventures including Bigrlyi, Malawiri, Walbiri, and Areva. The entity adopted its present name, Elevate Uranium Ltd, in May 2021, having previously been known as Marenica Energy Limited.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is overvalued on EV/EBITDA.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

18.07.2026 03:31

Meta Is in Talks with Anthropic to Lease Data Centers for $10 Billion — The New York Times

18.07.2026 01:33

U.S. stocks closed lower. Chipmakers had their worst week in more than a year.

18.07.2026 00:58

Adidas won the marketing battle against Nike at the World Cup. Investors took note.

18.07.2026 00:27

"A Hammer Blow": Analyst Sees IBM's Plunge as a Turning Point for the IT Industry

17.07.2026 23:48

"A Turning Point." An HSBC analyst recommended buying Apple stock

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026